A new market study, titled “Vitiligo Treatment Market Forecast 2021-2028” has been featured on Fortune Business Insights™.
***Get Latest Updated Market Research Report with Free Sample Report
Market Overview:
The Global Vitiligo Treatment Market is likely to gain impetus from an ever rising demand for innovative and modern treatment options for vitiligo. According to Fortune Business Insights, titled, “Vitiligo Treatment: Global Market Analysis, Insights and Forecast, 2019-2026,” the global vitiligo treatment market was valued at US$ 1,243.8 Mn in 2018. The market is projected to reach US$ 1,944.5 Mn by 2026, exhibiting a CAGR of 5.8% in the forecast period.
Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/vitiligo-treatment-market-100580
In terms of treatment, the global vitiligo treatment market is grouped into topical treatment, surgical procedures, light therapy, and others. Amongst these, the topical treatment segment had held majority of the vitiligo treatment market share. This is because of the increasing patient pool, need for numerous treatment methods for vitiligo, and an increasing number of research and development activities. However, lack of awareness regarding the available vitiligo treatment and reduction in the diagnosis rate may hamper the vitiligo treatment market growth.
Key Segmentation:
By Treatment
- Topical Treatment
- Light Therapy
- Surgical Procedures
By Disease Type
- Nonsegmental Vitiligo
- Segmental Vitiligo
By End User
- Hospitals
- Aesthetic Clinics
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Increasing Number of Vitiligo Patients to Favor Growth in Asia Pacific
The global vitiligo treatment market is geographically divided into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Amongst these, in Asia Pacific, India, China, and the other Southeast Asian countries have been witnessing huge patient pools of vitiligo.
This has further resulted in an urgent requirement for effective treatment options available of vitiligo. The markets of Latin America and the Middle East and Africa, on the other hand are expected witness notable grow in the near future. This is because darker skinned individuals who suffer from vitiligo are demanding for modern methods of treatment that would help the condition become less noticeable on them.
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vitiligo-treatment-market-100580
In North America, the vitiligo treatment market was valued at US$ 314.1 Mn in 2018. This is because of a rise in the research and development activities and an increasing adoption of vitiligo treatment. Numerous healthcare providers in the U.S., are also implementing advanced technologies in the treatment of vitiligo. Also, the number of vitiligo affected populace is growing rapidly there.
In Europe, an unmet need for advanced treatment options is likely to boost vitiligo treatment market growth. Fortune Business Insights predicts that Asia Pacific will witness a remarkably high CAGR during the forthcoming years. This is likely to occur because of huge patient pool in the region.
Some of the Main Key Players Covered in the Report
- Incyte Corporation
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- Baxter International Inc.
- Pfizer Inc.
- STRATA Skin Sciences
- Reddy’s Laboratories Ltd.
Key Players Focus on Effective Medicine Launch to Strengthen Market Position
Incyte Corporation, a pharmaceutical company, based in the U.S., announced the result of its dose-ranging, randomized, vehicle-controlled, and double-blind Phase 2 study evaluating ruxolitinib cream, an anti-inflammatory, nonsteroidal, and JAK inhibitor therapy in patients with vitiligo between the age group of 18 to 75 years of age. The results were out after 24 weeks.
The study met its primary goal and treated many patients with the help of ruxolitinib cream for 24 weeks. The results were presented at the 24th World Congress of Dermatology in Italy. The positive result supports the potential of ruxolitinib cream in providing novel treatment for chronic autoimmune disease.
Dr. Reddy’s Laboratories Ltd., a multinational pharmaceutical company, headquartered in Hyderabad, announced the launch of Melgain in June 2014. Melgain is a lotion that is considered to be the first peptide-based drug for vitiligo. The lotion is effective and very safe to use for the treatment of vitiligo for children and adults.
Fortune Business Insights profiles some of the most prominent companies operating in the global vitiligo treatment market. Some of them are Bausch Health Companies Inc., Dr. Reddy’s Laboratories Ltd., Incyte Corporation, Puneet Laboratories Pvt. Ltd, Astellas Pharma Inc., Baxter International Inc., and other players.
Some major points from Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of vitiligo by key countries
- Pipeline analysis
- Recent industry developments – mergers & acquisitions
- Recent developments in R&D
- Global Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Treatment
5.2.1. Topical Treatment
5.2.2. Light Therapy
5.2.3. Surgical Procedures
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Disease Type
5.3.1. Nonsegmental Vitiligo
….
- Middle East & Africa Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis – By Treatment
10.2.1. Topical Treatment
10.2.2. Light Therapy
10.2.3. Surgical Procedures
10.2.4. Others
10.3. Market Analysis – By Disease Type
10.3.1. Nonsegmental Vitiligo
10.3.2. Segmental Vitiligo
10.4. Market Analysis – By End-user
10.4.1. Hospitals
10.4.2. Aesthetic Clinics
10.4.3. Others
10.5. Market Analysis – By Country/Sub-region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
- Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1. Incyte Corporation
11.5.2. Astellas Pharma Inc.
11.5.3. Bausch Health Companies Inc.
11.5.4. Baxter International Inc.
11.5.5. Dr. Reddy’s Laboratories Ltd.
11.5.6. Pfizer Inc.
11.5.7. STRATA Skin Sciences
- Strategic Recommendation
NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights
Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd
Twitter: https://twitter.com/FBInsightPvtLtd
Fortune Business Insights 
2 comments